Prophylactic treatment of very premature infants with human surfactant.
about
Use of human surfactant low molecular weight apoproteins in the reconstitution of surfactant biologic activityPulmonary surfactant therapy.The adult respiratory distress syndrome. New insights into diagnosis, pathophysiology, and treatmentThe evolution of neonatology.Natural surfactant for neonatal respiratory distress syndrome in very premature infants: a 1992 update.Systematic review and meta-analysis of early postnatal dexamethasone for prevention of chronic lung disease.The pulmonary physician and critical care. 3. Pharmacotherapy in lung injury.Surfactant treatment and incidence of intraventricular haemorrhage in severe respiratory distress syndrome.Respiratory compliance in premature babies treated with artificial surfactant (ALEC).Role of prophylactic surfactant in preterm infantsBrain injury in chronically ventilated preterm neonates: collateral damage related to ventilation strategyFactors affecting surfactant responsiveness.Surfactants: past, present and future.Delivery and performance of surfactant replacement therapies to treat pulmonary disorders.Neonatology in the 1990's: surfactant replacement therapy becomes a reality.Surfactant treatment for premature babies--a review of clinical trials.Neonatal surfactant deficiency and surfactant replacement therapy.Occurrence, predictive factors and associated morbidity of bronchopulmonary dysplasia in a preterm birth cohort.Exogenous surfactant for the respiratory distress syndromeEvidence of fetal pulmonary aspiration of intra-amniotic administered surfactant in animal experiment.Natural surfactant substitution in respiratory distress syndrome.Effect of volume and dose on the pulmonary distribution of exogenous surfactant administered to normal rabbits or to rabbits with oleic acid lung injury.Acute and sustained effects of aerosolized vs. bolus surfactant therapy in premature lambs with respiratory distress syndrome.Surfactant and physiologic responses of preterm lambs to continuous positive airway pressure.Mikko Hallman --a major translator of basic science into neonatal medicine.
P2860
Q24561593-3F2397D8-A171-4FC5-8974-8A0A6ABC2F6DQ33608041-5FBBFA2C-F27A-4359-863B-CF58687DB38DQ33615952-EAE59113-D77C-4497-BA6A-ECD75863855BQ34395577-4D78BF63-FB53-4215-95B3-432236746F0EQ35204559-B3AB0402-9230-468D-9022-C0D56230AFC4Q35287062-9A9F89D7-B8AA-43F1-8DFF-90413056BDA2Q35428346-048DDDD4-7A3E-440F-AACE-3F2A73FBFB4FQ35605423-D27608BA-2C81-41C5-9292-00CCA31525A7Q35626498-3DAEE361-914D-4124-9F36-44F01F7E85D4Q36065555-3E43E24B-8F78-4080-B5F0-9B078F40CF29Q36218744-1DF8699A-6175-4280-A085-1DFBD20F7482Q36928292-1BD5F841-188A-4706-A254-C1179E9D00B8Q37150766-8B4BAC61-BC61-432F-9965-707184554701Q37341712-A919D6D7-EB1A-4B21-A72F-8ECFE3E10DDCQ37680410-6141AA2B-981F-4956-A2C6-604741CBBA0BQ37711816-1C20F00B-4647-4589-80C9-F2B52A8E2893Q37726142-11B27C9F-F91E-46CB-9CA6-63EA6E230B73Q41294342-F4496B68-84C8-460C-96B2-EDBDC5F9D46BQ42580195-9FEA0962-96A7-4B28-9777-0AE8B57A0423Q45043509-91245BF2-F9B3-4BC1-8D12-330BBC27365BQ45255194-3406F2AB-8E7A-4865-90E3-796BD3EB0736Q46099988-E90BB305-2368-426E-9D5C-B8EA597F5E18Q46656995-73892070-3456-49E5-B999-1EE93A28ED93Q47907480-84B38651-CB4D-4EEA-BDEA-0FACE34818D2Q48433880-D8DAB041-F8C6-4B20-BECA-7D80429AA005
P2860
Prophylactic treatment of very premature infants with human surfactant.
description
1986 nî lūn-bûn
@nan
1986年の論文
@ja
1986年学术文章
@wuu
1986年学术文章
@zh-cn
1986年学术文章
@zh-hans
1986年学术文章
@zh-my
1986年学术文章
@zh-sg
1986年學術文章
@yue
1986年學術文章
@zh
1986年學術文章
@zh-hant
name
Prophylactic treatment of very premature infants with human surfactant.
@en
Prophylactic treatment of very premature infants with human surfactant.
@nl
type
label
Prophylactic treatment of very premature infants with human surfactant.
@en
Prophylactic treatment of very premature infants with human surfactant.
@nl
prefLabel
Prophylactic treatment of very premature infants with human surfactant.
@en
Prophylactic treatment of very premature infants with human surfactant.
@nl
P2093
P1476
Prophylactic treatment of very premature infants with human surfactant.
@en
P2093
Benirschke K
Jarvenpaa AL
Merritt TA
Pohjavuori M
P304
P356
10.1056/NEJM198609253151301
P407
P577
1986-09-01T00:00:00Z